Related Experiment Videos
Drug product selection: the Florida experience revisited
American Journal of Public Health
|March 1, 1985
Summary
Florida pharmacists showed minimal change in drug product selection and brand interchange behaviors after the state's Drug Product Selection Law. Inadequate guidelines and liability concerns hindered expected increases in the drug selection rate.
Area of Science:
- Pharmacy Law and Practice
- Health Outcomes Research
Background:
- Florida enacted the Drug Product Selection (DPS) Law to encourage generic drug substitution.
- Understanding the impact of such legislation on pharmacist behavior is crucial for healthcare policy.
Purpose of the Study:
- To evaluate changes in drug product selection and brand interchange rates among Florida pharmacists post-DPS Law implementation.
- To identify factors influencing the adoption of drug product selection behaviors.
Main Methods:
- Comparative analysis of pharmacist behavior data collected approximately one year and four years after the DPS Law's passage.
- Qualitative assessment of potential barriers to increased drug product selection.
Main Results:
- Pharmacist behavior regarding product selection and brand interchange remained largely unchanged between the two measurement points.
- Limited increase in the state's DPS rate was observed, contrary to expectations.
Conclusions:
- The expected increase in drug product selection rates was not realized, suggesting limited impact of the DPS Law in its initial years.
- Lack of clear state guidelines and pharmacist concerns about liability appear to be significant barriers to increased drug product selection.